Search results
Results from the WOW.Com Content Network
The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases.
The funding from the award will be disbursed in two installments, with an initial sum of about $65.7 million accessible immediately to facilitate ongoing study start-up endeavors.
Brings total awards from BARDA to $110 million for development of broad SARS-CoV-2 and Influenza multispecifics, with potential funding of up to $205 million if all options are executed; Development work is based on ModeX proprietary MSTAR technology that incorporates multiple antibody binding sites into a single molecule
The funding is part of a partnership with the Biomedical Advanced Research and Development Authority (BARDA). Under the multi-year contract CSL will deliver its MF59 adjuvant, an ingredient that ...
The new award follows a $483 million grant provided by BARDA in April, which means Moderna has now received a total of $955 million in funding from the U.S. government.The award coincides with the ...
Significant funding goes to BARDA (Biomedical Advanced Research and Development Authority), part of DHHS. Funding for activities aimed at prevention has more than doubled since 2007 and is distributed among 11 federal agencies. [26] Efforts toward cooperative international action are part of the project.
Operation Warp Speed, initially funded with about $10 billion from the CARES Act (Coronavirus Aid, Relief, and Economic Security) passed by the United States Congress on March 27, 2020, [1] was an interagency program that includes components of the Department of Health and Human Services, including the Centers for Disease Control and Prevention ...
Marinus Pharmaceuticals Inc (NASDAQ: MRNS) announced that the Biomedical Advanced Research and Development Authority (BARDA) exercised its first contract option, valued at approximately $12.3 ...